
Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.

Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.

A multiple sclerosis expert, Dr Darin Okuda reviews long-term outcomes with ozanimod in DAYBREAK trial based on the number of relapses that was presented at EAN 2022.

Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.

Published: August 4th 2022 | Updated:

Published: August 4th 2022 | Updated:

Published: August 4th 2022 | Updated: